| P50 | author | Daniela Russo | Q54251021 |
| | Gennaro Ilardi | Q56588244 |
| | Gaetano De Rosa | Q58354922 |
| | Francesco Merolla | Q75231127 |
| P2093 | author name string | Massimo Mascolo | |
| | Stefania Staibano | |
| | Maria Siano | |
| P2860 | cites work | DNA methylation patterns and epigenetic memory | Q22065780 |
| | Translating the Histone Code | Q22065840 |
| | Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review | Q22306450 |
| | CBP/p300-mediated acetylation of histone H3 on lysine 56 | Q24657910 |
| | Global cancer statistics, 2002 | Q27860562 |
| | Cancer statistics, 2008 | Q27860585 |
| | Worms gang up on bacteria | Q27860588 |
| | The language of covalent histone modifications | Q27860931 |
| | MicroRNA signatures in human cancers | Q27860962 |
| | CAF-1 and the inheritance of chromatin states: at the crossroads of DNA replication and repair | Q28140667 |
| | Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells | Q28245307 |
| | Identification of a microRNA signature associated with progression of leukoplakia to oral carcinoma | Q28259466 |
| | mir-17-92, a cluster of miRNAs in the midst of the cancer network | Q28275929 |
| | Genetic unmasking of an epigenetically silenced microRNA in human cancer cells | Q28288806 |
| | Smoking and drinking in relation to oral and pharyngeal cancer | Q28297089 |
| | Case-control study of human papillomavirus and oropharyngeal cancer | Q28301695 |
| | Epigenetics in human disease and prospects for epigenetic therapy | Q29547437 |
| | DNA methylation and human disease | Q29615417 |
| | Aberrant expression of histone deacetylase 6 in oral squamous cell carcinoma | Q40268206 |
| | Sequence-dependent interaction between cisplatin and histone deacetylase inhibitors in human oral squamous cell carcinoma cells. | Q40295536 |
| | Antimitogenic and chemosensitizing effects of the methylation inhibitor zebularine in ovarian cancer | Q40361522 |
| | Effects of demethylating agent 5-aza-2(')-deoxycytidine and histone deacetylase inhibitor FR901228 on maspin gene expression in oral cancer cell lines | Q40519779 |
| | Differential methylation status of tumor-associated genes in head and neck squamous carcinoma: incidence and potential implications. | Q40550032 |
| | Chromatin assembly factor-1, a marker of clinical value to distinguish quiescent from proliferating cells | Q40571002 |
| | Hypermethylation of the retinoic acid receptor-beta(2) gene in head and neck carcinogenesis. | Q40579956 |
| | Immunohistochemical evidence of PTEN in oral squamous cell carcinoma and its correlation with the histological malignancy grading system | Q40634516 |
| | Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation | Q40732720 |
| | The E-cadherin gene is silenced by CpG methylation in human oral squamous cell carcinomas | Q40789578 |
| | E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. | Q41158814 |
| | Chromatin assembly coupled to DNA repair: a new role for chromatin assembly factor I. | Q41166774 |
| | p53 alterations in human squamous cell carcinomas and carcinoma cell lines | Q42755072 |
| | H3K4 histone methylation in oral squamous cell carcinoma. | Q43276786 |
| | Potential of 5-aza-2'-deoxycytidine (Decitabine) a potent inhibitor of DNA methylation for therapy of advanced non-small cell lung cancer | Q43822201 |
| | The proliferation marker Chromatin Assembly Factor-1 is of clinical value in predicting the biological behaviour of salivary gland tumours. | Q43865977 |
| | Promoter methylation and silencing of PTEN in gastric carcinoma | Q43918868 |
| | Overexpression of chromatin assembly factor-1 (CAF-1) p60 is predictive of adverse behaviour of prostatic cancer. | Q44112283 |
| | DNA promoter hypermethylation in saliva for the early diagnosis of oral cancer | Q44354694 |
| | Resetting the histone code at CDKN2A in HNSCC by inhibition of DNA methylation | Q44679410 |
| | Epigenetic therapy using the histone deacetylase inhibitor for increasing therapeutic gain in oral cancer: prevention of radiation-induced oral mucositis and inhibition of chemical-induced oral carcinogenesis | Q46058177 |
| | Effects of histone deacetylase inhibitor FR901228 on the expression level of telomerase reverse transcriptase in oral cancer | Q46404919 |
| | High frequency of hypermethylation of p14, p15 and p16 in oral pre-cancerous lesions associated with betel-quid chewing in Sri Lanka | Q46745649 |
| | Human papillomavirus prevalence and types in newborns and parents: concordance and modes of transmission | Q47296533 |
| | p16, MGMT, RARbeta2, CLDN3, CRBP and MT1G gene methylation in esophageal squamous cell carcinoma and its precursor lesions. | Q50730925 |
| | A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. | Q51908580 |
| | Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control. | Q52545574 |
| | Homozygous deletion of the PTEN tumor-suppressor gene is not a feature in oral squamous cell carcinoma. | Q52827239 |
| | Gene hypermethylation in tumor tissue of advanced oral squamous cell carcinoma patients. | Q53378709 |
| | Co-overexpression of p53 and c-myc proteins linked with advanced stages of betel- and tobacco-related oral squamous cell carcinomas from eastern India. | Q53429879 |
| | Head and neck cancer | Q54152939 |
| | Methylation analysis of cancer-related genes in non-neoplastic cells from patients with oral squamous cell carcinoma. | Q54384407 |
| | WNT pathway in oral cancer: epigenetic inactivation of WNT-inhibitors. | Q54413025 |
| | Involvement of PTEN promoter methylation in cerebral cavernous malformations. | Q54500778 |
| | Promoter hypermethylation profile of tumor-associated genes p16, p15, hMLH1, MGMT and E-cadherin in oral squamous cell carcinoma. | Q54780765 |
| | The fundamental role of epigenetic events in cancer | Q56421597 |
| | The history of cancer epigenetics | Q29617273 |
| | The epigenetic progenitor origin of human cancer | Q29617486 |
| | Alterations of p16(INK4a) and p14(ARF) in patients with severe oral epithelial dysplasia. | Q30714821 |
| | Differential DNA methylation profiles in gynecological cancers and correlation with clinico-pathological data | Q31056438 |
| | Evidence for a causal association between human papillomavirus and a subset of head and neck cancers | Q33180284 |
| | The E6 protein of human papillomavirus type 16 binds to and inhibits co-activation by CBP and p300. | Q33292571 |
| | The role of pyrosequencing in head and neck cancer epigenetics: correlation of quantitative methylation data with gene expression | Q33324200 |
| | Overexpression of Chromatin Assembly Factor-1/p60 helps to predict the prognosis of melanoma patients | Q33533679 |
| | Advances and Perspectives in the Molecular Diagnosis of Head and Neck Cancer | Q33610394 |
| | Hypermethylation of tumor suppressor genes in cancer | Q33765677 |
| | Melanoma: Stem cells, sun exposure and hallmarks for carcinogenesis, molecular concepts and future clinical implications | Q33822119 |
| | Negative regulation of tumor suppressor p53 by microRNA miR-504 | Q33979178 |
| | Epigenetics of human cutaneous melanoma: setting the stage for new therapeutic strategies | Q33980682 |
| | Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC). | Q34011808 |
| | Human papillomavirus: changing paradigms in oropharyngeal cancer | Q34112659 |
| | Patterns of gene promoter methylation in squamous cell cancer of the head and neck | Q34135226 |
| | Human papillomavirus as a risk factor for oral squamous cell carcinoma: a meta-analysis, 1982-1997. | Q34279292 |
| | DNA methylation, chromatin inheritance, and cancer | Q34290318 |
| | Cell-type-specific signatures of microRNAs on target mRNA expression | Q34479693 |
| | CAF-I-dependent control of degradation of the discontinuous strands during mismatch repair | Q34582950 |
| | Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States | Q34743604 |
| | Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial | Q34749494 |
| | Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers | Q34760882 |
| | Gene expression profiling predicts the development of oral cancer. | Q34782013 |
| | DNA methylation and genomic imprinting: insights from cancer into epigenetic mechanisms | Q34793031 |
| | Epigenetic alterations in head and neck cancer: prevalence, clinical significance, and implications | Q35642648 |
| | Viral oncoproteins target the DNA methyltransferases | Q35954845 |
| | The epigenetics of oral cancer | Q36254262 |
| | Prognostic value of human papillomavirus in the survival of head and neck cancer patients: an overview of the evidence. | Q36279875 |
| | Chromatin modifier enzymes, the histone code and cancer | Q36287031 |
| | Human papillomavirus as an independent predictor in oral squamous cell cancer. | Q36330781 |
| | Combination therapy with DNA methyltransferase inhibitors in hematologic malignancies | Q36338031 |
| | DNA methylation and gene silencing in cancer | Q36338042 |
| | Promoter methylation and inactivation of tumour-suppressor genes in oral squamous-cell carcinoma | Q36358803 |
| | The many faces of chromatin assembly factor 1. | Q36998656 |
| | The binding of histone deacetylases and the integrity of zinc finger-like motifs of the E7 protein are essential for the life cycle of human papillomavirus type 31. | Q37010892 |
| | Chromatin assembly factors Asf1 and CAF-1 have overlapping roles in deactivating the DNA damage checkpoint when DNA repair is complete | Q37078952 |
| | HPV in oral squamous cell carcinoma vs head and neck squamous cell carcinoma biopsies: a meta-analysis (1988-2007). | Q37193014 |
| | Applying the molecular biology and epigenetics of head and neck cancer in everyday clinical practice | Q37233394 |
| | DNA methylation in circulating tumour DNA as a biomarker for cancer | Q37280956 |
| | DNA methylomes, histone codes and miRNAs: tying it all together | Q37286430 |
| | Genetic modelling of the PTEN/AKT pathway in cancer research | Q37305035 |
| | Chromatin reassembly signals the end of DNA repair | Q37344576 |
| | Real time investigation of protein folding, structure, and dynamics in living cells | Q37386070 |
| | The p53 tumour suppressor gene | Q37751892 |
| | Human papillomavirus detection in head and neck squamous cell carcinomas. | Q37802139 |
| | Histone deacetylase inhibitors for the treatment of myelodysplastic syndrome and acute myeloid leukemia | Q37813392 |
| | Methylation in oral cancer and pre-cancerous lesions (Review). | Q37850338 |
| | Genetics/epigenetics of oral premalignancy: current status and future research | Q37850474 |
| | Human papillomaviruses in oral carcinoma and oral potentially malignant disorders: a systematic review. | Q37850481 |
| | MicroRNAs: new actors in the oral cancer scene | Q37862866 |
| | DNA hypermethylation as an epigenetic mark for oral cancer diagnosis. | Q37886046 |
| | MicroRNAs in an oral cancer context - from basic biology to clinical utility | Q37968114 |
| | E-cadherin in oral SCC: an analysis of the confusing literature and new insights related to its immunohistochemical expression | Q37972270 |
| | Ras oncogenes in oral cancer: the past 20 years | Q37975342 |
| | National prevalence of oral HPV infection and related risk factors in the U.S. adult population. | Q37976478 |
| | Epigenetic silencing of CRABP2 and MX1 in head and neck tumors | Q38347884 |
| | Comparative prognostic value of HPV16 E6 mRNA compared with in situ hybridization for human oropharyngeal squamous carcinoma. | Q38419382 |
| | Loss of PTEN expression as a prognostic marker for tongue cancer | Q38458513 |
| | The incidence of p53 mutations increases with progression of head and neck cancer | Q38485045 |
| | Expression of members of the miRNA17-92 cluster during development and in carcinogenesis | Q39527093 |
| | Influence of oral sex and oral cancer information on young adults' oral sexual-risk cognitions and likelihood of HPV vaccination | Q39665529 |
| | A microarray-based DNA methylation study of glioblastoma multiforme | Q39834071 |
| | Identification of candidate tumor suppressor genes inactivated by promoter methylation in melanoma | Q39938055 |
| | Epigenetic inactivation of SFRP genes in oral squamous cell carcinoma. | Q39979546 |
| | Identification of pyruvate kinase type M2 as potential oncoprotein in squamous cell carcinoma of tongue through microRNA profiling | Q39984445 |
| | Quantitative promoter hypermethylation analysis of cancer-related genes in salivary gland carcinomas: comparison with methylation-specific PCR technique and clinical significance | Q39986335 |
| | Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer | Q39996295 |
| | Epigenetic inactivation of RASSF2 in oral squamous cell carcinoma. | Q40009864 |
| | Epigenetic regulation of chemosensitivity to 5-fluorouracil and cisplatin by zebularine in oral squamous cell carcinoma. | Q40056385 |
| | Tumor suppressor activity of CCAAT/enhancer binding protein alpha is epigenetically down-regulated in head and neck squamous cell carcinoma | Q40131344 |
| | Enhancement of cisplatin induced apoptosis by suberoylanilide hydroxamic acid in human oral squamous cell carcinoma cell lines | Q40143670 |
| | Chemosensitization of oral squamous cell carcinoma cells to cisplatin by histone deacetylase inhibitor, suberoylanilide hydroxamic acid | Q40153604 |
| | Gene promoter hypermethylation in tumors and serum of head and neck cancer patients | Q57240069 |
| | Chromatin assembly factor-1 (CAF-1)-mediated regulation of cell proliferation and DNA repair: a link with the biological behaviour of squamous cell carcinoma of the tongue? | Q57765027 |
| | Quantitative methylation analysis of resection margins and lymph nodes in oral squamous cell carcinoma | Q58068561 |
| | Versatile assembler | Q59043157 |
| | Loss of E-cadherin expression resulting from promoter hypermethylation in oral tongue carcinoma and its prognostic significance | Q59344212 |
| | Chromosomal Instability and Tumors Promoted by DNA Hypomethylation | Q63253103 |
| | Clinical significance and prognostic value of chromatin assembly factor-1 overexpression in human solid tumours | Q63383590 |
| | Defective S phase chromatin assembly causes DNA damage, activation of the S phase checkpoint, and S phase arrest | Q73086545 |
| | Defence of IARC monographs | Q73281736 |
| | PTEN methylation is associated with advanced stage and microsatellite instability in endometrial carcinoma | Q73374555 |
| | High frequency of homozygous deletion and methylation of p16(INK4A) gene in oral squamous cell carcinomas | Q73412079 |
| | Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients | Q73548955 |
| | Reduced expression of E-cadherin in oral squamous cell carcinoma: relationship with DNA methylation of 5' CpG island | Q74151993 |
| | Infrequent genetic alterations of the tumor suppressor gene PTEN/MMAC1 in squamous cell carcinoma of the oral cavity | Q74443207 |
| | Concurrent hypermethylation of multiple regulatory genes in chewing tobacco associated oral squamous cell carcinomas and adjacent normal tissues | Q75204916 |
| | Inactivation of the PTEN gene by mutation, exonic deletion, and loss of transcript in human oral squamous cell carcinomas | Q78347853 |
| | The correlation between CpG methylation and protein expression of P16 in oral squamous cell carcinomas | Q78355107 |
| | Aberrant methylation of multiple genes and clinicopathological features in oral squamous cell carcinoma | Q78358416 |
| | Histone deacetylase 2 expression predicts poorer prognosis in oral cancer patients | Q79704844 |
| | Aberrant promoter hypermethylation of p16 and MGMT genes in oral squamous cell carcinomas and the surrounding normal mucosa | Q79768864 |
| | MGMT expression in oral precancerous and cancerous lesions: correlation with progression, nodal metastasis and poor prognosis | Q80333284 |
| | An association of DNMT3b protein expression with P16INK4a promoter hypermethylation in non-smoking female lung cancer with human papillomavirus infection | Q80349273 |
| | PTEN expression and methylation status in oral squamous cell carcinoma | Q81323758 |
| | Prognostic significance of N-Cadherin expression in oral squamous cell carcinoma | Q83135320 |
| | Methylation of RASSF1A, RASSF2A, and HIN-1 is associated with poor outcome after radiotherapy, but not surgery, in oral squamous cell carcinoma | Q84030785 |
| | Interaction between the MTHFR C677T polymorphism and alcohol--impact on oral cancer risk and multiple DNA methylation of tumor-related genes | Q85183995 |
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | squamous cell carcinoma | Q681817 |
| | oral cavity neoplasm | Q55789538 |
| | lip and oral cavity carcinoma | Q55790434 |
| | genetic epigenesis | Q64443099 |
| | neoplastic gene expression regulation | Q66660300 |
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 2331-2353 | |
| P577 | publication date | 2012-02-21 | |
| P1433 | published in | International Journal of Molecular Sciences | Q3153277 |
| P1476 | title | Epigenetic disregulation in oral cancer | |
| P478 | volume | 13 | |